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Abstract
Notch signaling has been implicated in the regulation of smooth muscle differentiation, but the precise role of Notch
receptors is ill defined. Although Notch3 receptor expression is high in smooth muscle, Notch3 mutant mice are viable and
display only mild defects in vascular patterning and smooth muscle differentiation. Notch2 is also expressed in smooth
muscle and Notch2 mutant mice show cardiovascular abnormalities indicative of smooth muscle defects. Together, these
findings infer that Notch2 and Notch3 act together to govern vascular development and smooth muscle differentiation. To
address this hypothesis, we characterized the phenotype of mice with a combined deficiency in Notch2 and Notch3. Our
results show that when Notch2 and Notch3 genes are simultaneously disrupted, mice die in utero at mid-gestation due to
severe vascular abnormalities. Assembly of the vascular network occurs normally as assessed by Pecam1 expression,
however smooth muscle cells surrounding the vessels are grossly deficient leading to vascular collapse. In vitro analysis
show that both Notch2 and Notch3 robustly activate smooth muscle differentiation genes, and Notch3, but not Notch2 is a
target of Notch signaling. These data highlight the combined actions of the Notch receptors in the regulation of vascular
development, and suggest that while these receptors exhibit compensatory roles in smooth muscle, their functions are not
entirely overlapping.
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Introduction
The Notch family of receptors is evolutionarily conserved and
critical for cell fate determination and differentiation [1,2]. Each of
the four Notch receptors present in mammals (Notch 1–4) is
activated by a membrane-bound ligand (Jagged-1,2/Delta-like-
1,3,4), which promotes receptor cleavage releasing a Notch
intracellular domain (NICD) that translocates to the nucleus. In
the nucleus, the NICD binds to the transcription factor CSL (CBF-
1/RBP-Jk, Su(H), and Lag-1) and regulates downstream gene
expression such as Hes (hairy/enhancer of split) and Hey (Hairy-
related, also referred to as Hrt, CHF, HESR) family members [3].
In the vasculature, Notch activation regulates the expression of
angiogenic factors, including members of the vascular endothelial
growth factor (VEGF) pathway [4], and platelet-derived growth
factor receptor-ß [5]. Not surprisingly, functional studies have
demonstrated a role for Notch signaling in angiogenic remodeling,
arterial/venous specification, and in endothelial tip cell differen-
tiation [6,7]. While, many of these studies focused on the actions of
Notch signaling in the endothelium, others have identified a role
for Notch activation in vascular smooth muscle development [8].
One report showed that expression of the Notch ligand Jagged1
(Jag1) on endothelial cells is essential for neighboring vascular
smooth muscle differentiation [9], indicating a requirement for
Notch receptors on smooth muscle cells. The Notch3 receptor is
highly enriched in smooth muscle [10,11] and Notch3 knockout
mice, while viable, display vascular smooth muscle defects
associated with postnatal maturation and arterial specification
[12,13]. We previously demonstrated that differentiation of
vascular smooth muscle cells by endothelial cells was dependent
upon NOTCH3 [14]. Notch2 is more widely expressed than
Notch3, but is also present in vascular smooth muscle cells
[11,15,16]. Two studies in particular have hinted at a role in
smooth muscle cell regulation. McCright et al., reported that
Notch2 hypomorphic knockout mice exhibit widespread hemor-
rhaging mid to late gestation [17]. Whereas, a neural crest-specific
deletion of Notch2 causes an underdeveloped outflow tract due to
decreased smooth muscle [15]. Thus, given the collective evidence
for a role of the Notch receptors in regulating smooth muscle
differentiation, we hypothesized that multiple Notch receptors,
particularly Notch2 and Notch3 act together to regulate vascular
smooth muscle differentiation. Here, we perform a phenotypic
analysis of mice deficient in the Notch2 and Notch3 genes. Our
results show that together these genes regulate vascular smooth
muscle development. Mice deficient in both genes die during mid-
gestation from severe vascular defects associated with an absence
of differentiated smooth muscle cells. These data are the first to
demonstrate a critical role for these Notch receptors in vascular
development, and highlight the combined role they play in
regulating smooth muscle differentiation.
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Combined mutations in Notch2 and Notch3 genes cause
embryonic lethality
Prior analysis showed that Notch3 null mice are viable and fertile
with minor, yet significant postnatal defects in smooth muscle
structure and vascular function [12,13,18]. Because Notch2 is also
expressed in smooth muscle and a neural crest-specific Notch2
mutation causesvascular patterningdefects[11,15,16],we set out to
determine the phenotype of mice with a combined deficiency in the
Notch2andNotch3genes.Wecrossed previouslygeneratedNotch2
hypomorph [17] and Notch3 null [19] mice to create double
heterozygotes (Notch2
2/+;Notch3
2/+), which we intercrossed to
generate the genotypes for comparison. From a double heterozy-
gous cross, nine different genotypes were produced. Initial analysis
indicated that the Notch2
2/2;Notch3
2/2 embryos did not survive to
embryonic day (E)12.5 of gestation (Table S1). Double mutant
embryos were recovered at expected Mendelian ratios at this time
point, however all Notch2
2/2;Notch3
2/2 embryos were small, pale
(bloodless) and were being resorbed. At E11.5 the Notch2
2/2;
Notch3
2/2 embryos were easily distinguishable from wildtype and
heterozygouslittermateswithobvioussignsofhemorrhagingandyolk
sac defects. This primary analysis indicated that the combined loss of
Notch2 and Notch3 resulted in embryonic lethality around E11.5;
thus we focused on this time point and those just prior to determine
the cause of lethality.
For simplicity, we chose to perform a comparative examination
of wildtype embryos with the three genotypes harboring homo-
zygous mutant alleles alone and in combination (Notch2
2/2;
Notch3
+/+, Notch2
+/+;Notch3
2/2, Notch2
2/2;Notch3
2/2). Gross anal-
ysis of the yolk sacs by light microscopy revealed normal vascular
patterning in wildtype and single mutant embryos at E10.5,
however 45% of the double mutant yolk sacs had a decrease in
visible blood vessels (Figure 1A and Table 1). At E11.5, 92% of
double mutant embryos had reduced blood vessels in the yolk sacs
(Figure 1A, and Table 1), while only a small percentage of the
Notch2 and Notch3 mice had observable vascular defects within
their yolk sacs (Table 1). Examination of the embryo proper at
E10.5 showed that all genotypes were phenotypically normal and
appeared similar in size with no apparent structural defects
(Figure 1B). At E11.5, double mutant embryos had a combination
of abdominal and cerebral hemorrhaging, pericardial effusion, and
in some cases were smaller in size (Figure 1B). The Notch3
2/2 mice
were indistinguishable from the wildtype embryos and a small
percentage of Notch2
2/2 mice exhibited visible hemorrhaging,
consistent with previous findings [17]. These data suggested that
the primary defect of the mutant embryos was vascular
insufficiency leading to the demise of the embryos. To examine
potential structural defects of blood vessels, embryos were cross-
sectioned and stained with hematoxylin and eosin (H&E). At
E10.5, the overall structure of the blood vessels from the four
different genotypes were indistinguishable, with all having intact
vessel walls (Figure S1). At E11.5, embryos deficient in both
Notch2 and Notch3 had severely compromised blood vessel
structure (Figure 2). Vessels were enlarged and filled with blood,
suggesting improper flow, while the vessel walls were thin and in
certain cases appeared to incompletely enclose the lumen. The
defect was observed in the dorsal aorta and caudal aorta (Figure 2),
and was also apparent in smaller arteries like the carotid arteries
(not shown). In contrast, the overall structure of the blood vessels
in the Notch2
2/2 and Notch3
2/2 embryos at E11.5 was similar to
wildtype.
Notch2 and Notch3 double mutants show deficiencies in
smooth muscle cells
We stained whole embryos with the endothelial cell marker
Pecam1 and the smooth muscle marker smooth muscle a-actin
(SMA) to assess the overall structure of the blood vessels in mutant
embryos. At E10.5, Pecam1 staining in the double mutant embryos
appeared similar to wildtype and the single mutant embryos,
indicating that vascular patterning was grossly normal and endothe-
lial cells were being properly positioned (Figure 3A). Staining with
SMA showed similar expression levels in the heart of all genotypes,
but the Notch2
2/2;Notch3
2/2 embryos and Notch2
2/2 embryos
exhibited a decrease in the SMA staining within the paired dorsal
aorta (Figure 3B). These data indicated that the loss of Notch2 and
the combined loss of Notch2 and Notch3 result in a decrease in
smooth muscle cells surrounding the blood vessel walls. Section
staining through blood vessels at E10.5 and E11.5 showed a
consistent result with the whole mount analysis. At E10.5, Pecam1
expression showed a similar patterning in all genotypes, while SMA
expression was greatly reduced in both the Notch2
2/2 and Notch2
2/2;
Notch3
2/2 embryos (Figure 4A, Figure S2). At this stage SMA
expression appeared mottled, with many vessels exhibiting SMA
staining that was asymmetrically localized. At E11.5, the expression
pattern of Pecam1 was decreased in the doublemutant embryos, with
SMA expression barely detectable (Figure 4B, Figure S2). Notch2
mutant mice had reduced Pecam1 staining compared to wildype and
Notch3
2/2 embryos, and showed SMA staining that was moderately
reduced from wildtype (Figure 4B, Figure S2). Collectively, our results
show that at E10.5, vessels from Notch2
2/2 and Notch2
2/2;Notch3
2/2
embryos are similar, however at E11.5, the loss of both genes causes a
dramatic reduction in SMA staining and compromised vessel
structure. These defects were exclusive to smooth muscle of
Figure 1. Combined mutations in Notch2 and Notch3 cause
defects in vascular development. Yolk sacs (A) and embryos (B) at
E10.5 and E11.5 were dissected and photographed with a stereo
microscope. At E10.5, Notch2
2/2;Notch3
2/2 (N2
2/2;N3
2/2) embryos
exhibit a decrease in yolk sac blood vessels, while the embryo proper is
relatively normal in appearance. At E11.5, Notch2
2/2;Notch3
2/2 mice
show severe vascular defects in both yolk sac and embryo. Yolk sac
blood vessels are not visible and extensive hemorrhaging is seen in the
embryo (arrowhead). Blood vessels are grossly normal in Notch2
2/2
(N2
2/2;N3
+/+) and Notch3
2/2 (N2
+/+;N3
2/2) embryos. Scale bar=1 mm.
doi:10.1371/journal.pone.0037365.g001
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myocardium was comparable to wildtype (Figure S3).
Combined Notch2 and Notch3 mutations cause yolk sac
defects
Our initial analysis showed that the yolk sac vasculature is
disrupted in double mutant embryos, so we additionally analyzed
these blood vessels to determine if similar defects existed in this
vascularized tissue. Yolk sac blood vessels at E11.5 had slightly
reduced amounts of Pecam1 staining in both the Notch2
2/2 and
Notch2
2/2;Notch3
2/2 genotypes and reduced SMA expression
(Figure 5). Similar to the embryos, the yolk sac vessels of the
double mutant mice appeared structurally fragile, and in many
instances were collapsed. Because yolk sacs are a highly
vascularized tissue, we used this tissue to assess gene expression
of smooth muscle markers and Notch signaling targets by qPCR
(Figure 6). SMA RNA levels showed a decrease consistent with
immunofluorescence staining, and another early marker of smooth
muscle cells, SM22a exhibited a decrease at E10.5 but not at
E11.5. The pronounced decrease observed at E10.5 compared to
E11.5 likely reflects continued expression of these markers in
nonvascular cells within the whole yolk sac. A later smooth muscle
marker gene, Calponin-h1 (Cnn1) exhibited decreased transcripts
in all mutant genotypes at E11.5, but not E10.5. Consistent with
our immunohistochemistry results, Pecam1 expression was normal
at E10.5, and showed a reduction at E11.5 in all mutant
genotypes. Examination of Notch target genes indicated no
significant difference in Hes1 expression and a small decrease in
Hey2. Heyl expression was dramatically affected by the loss of
Notch2 and the combined Notch2/Notch3 mutant, but only
slightly affected by the loss of Notch3.
Notch2 and Notch3 activate downstream targets with
similar efficiency
Because our results suggested that both Notch2 and Notch3
contribute to smooth muscle differentiation we wanted to
determine if they could directly activate smooth muscle-specific
gene expression. We overexpressed the intracellular domains of
the Notch2 (NICD2) and Notch3 (NICD3) by lentiviral infection
of human aortic smooth muscle cells and examined gene
expression by qPCR. Both NICD2 and NICD3 activated the
expression of smooth muscle differentiation genes SMA, CNN1
and smooth muscle myosin heavy chain (SM-MHC) (Figure 7A).
Figure 2. Embryos lacking both Notch2 and Notch3 have
disrupted blood vessels. Hematoxylin and eosin staining of
transverse sections of E11.5 embryos through the heart and midsection
(A–D), descending aorta (E–H), and caudal aorta (I–L). In the Notch2
2/2;
Notch3
2/2 (N2
2/2;N3
2/2) embryos, the paired dorsal aorta is expanded
in size and filled with blood (D, arrowheads). Higher magnification of
blood vessels in double mutant embryos show a lack of cells
surrounding the lumen (H, L). The overall structure of blood vessels
appears relatively normal in the single Notch2
2/2 (N2
2/2;N3
+/+) and
Notch3
2/2 (N2
+/+;N3
2/2) mice. Scale bar=100 mm. (H) heart, (nt) neural
tube.
doi:10.1371/journal.pone.0037365.g002
Table 1. Notch2 (N2) and Notch3 (N3) mutant embryos with
yolk sac defects.
Genotypes
Age N2
+/+;N3
+/+ N2
2/2;N3
+/+ N2
+/+;N3
2/2 N2
2/2;N3
2/2
E10.5 % 0% 0% 0% 45%
# 0o f1 4 0o f1 7 0o f1 8 1 0o f2 2
E11.5 % 0% 11% 8% 92%
# 0o f1 6 2o f1 9 1o f1 3 1 2o f1 3
doi:10.1371/journal.pone.0037365.t001
Figure 3. Notch2
2/2 and Notch2
2/2;Notch3
2/2 embryos devel-
op a normal vascular plexus but have disrupted vascular
smooth muscle cells. Whole-mount embryos at E10.5 were stained
for Pecam1 (A) or SMA (B). The vascular plexus is well formed in all
mutant embryos with normal vessel patterning seen in large vessels (A,
upper panels) and smaller intersomitic vessels (A, lower panels). Whole-
mount immunostaining for SMA demonstrates less SMA-positive cells in
the dorsal aorta of Notch2
2/2 (N2
2/2;N3
+/+) and Notch2
2/2;Notch3
2/2
(N2
2/2;N3
2/2) (B, lower panels) embryos compared to wildtype and
Notch3
2/2 (N2
+/+;N3
2/2) embryos. Arrowheads point to paired dorsal
aorta. Scale bar=1 mm. (H) heart.
doi:10.1371/journal.pone.0037365.g003
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Notch target genes (Figure 7B). Previously we showed that
NOTCH3 was induced in smooth muscle by Notch signaling
and could activate its own transcription through autoregulation
[14]. Consistent with this, NICD3 activated transcription of the
endogenous NOTCH3 gene, but was not able to induce the
expression of NOTCH2 in aortic smooth muscle cells. NICD2
could also promote the expression of NOTCH3, but could not
induce the expression of endogenous NOTCH2 transcripts
(Figure 7C). Overall, our data demonstrate a critical role for
Notch signaling in the development of vascular smooth muscle
cell, and indicate that Notch2 and Notch3 have overlapping yet
distinct roles in governing smooth muscle differentiation.
Discussion
Although several lines of evidence have implicated Notch
signaling in vascular smooth muscle development, the data
supporting this notion has been less conclusive. Here we show
that combined mutations of Notch2 and Notch3 genes in mice
results in severe cardiovascular defects with the underlying cause
due to a lack of smooth muscle differentiation. Previous studies on
Notch receptor function in vascular smooth muscle cells have
largely focused on Notch3, due to its relatively specific expression
within this cell type and the known association with the human
cerebral vascular disease, cerebral autosomal dominant arteriop-
athy with subcortical infarcts and leukoencephalopathy (CADA-
SIL) [10,11,20]. Data from knockout mice indicated that loss of
Notch3 results in smooth muscle maturation defects and causes
deficiencies in arterial specification [12]. Further studies with
postnatal mice revealed a role for Notch3 in the regulation of
proliferation and vascular tone [18,21]; however, Notch3 null
mice undergo a normal restenosis response following vascular
injury [22]. These data clearly indicate that Notch3 regulates
aspects of smooth muscle function, but is non-essential for smooth
muscle differentiation. In vitro data from our lab indicated that
Notch3 drives expression of smooth muscle genes, and in a model
of endothelial cell-induced smooth muscle differentiation, Notch3
is critical for smooth muscle gene expression [14].
While previous data showed that other Notch receptors do not
compensate in the absence of Notch3 through increased expres-
sion [11], their presence in smooth muscle cells may contribute to
smooth muscle differentiation. Indeed, Notch2 has been shown to
be strongly expressed in smooth muscle and data from knockout
mice show cardiac outflow tract anomalies consistent with smooth
muscle defects [15,17]. Because Notch2 null mice die very early
due to massive cell death [16], in this study we utilized a
hypomorphic allele, which had been previously characterized to
have cardiovascular defects [17]. However the smooth muscle
differentiation profile of these hypomorphic mice had not been
reported. In our analysis we show for the first time, that Notch2
hyopmorphic mice have a loss of smooth muscle markers as early
as E10.5, which likely leads to later defects associated with
hemorrhage and outflow tract defects. In contrast, Notch3 null
mice at E10.5 exhibit normal vascular structure, with no apparent
signs of defects. Loss of function of the two Notch genes gives rise
to a complete breakdown of the vascular wall at E11.5. At E10.5,
the expression of SMA looks comparable in the Notch2 and
double mutant embryos, suggesting that Notch2 activity predom-
inates at this early stage, however at E11.5, the double mutant
vessels appear to lose most of their smooth muscle cells, while the
Notch2 embryos retain the expression of smooth muscle marker,
Figure 4. Notch2 and Notch2/Notch3 double mutant embryos
exhibit diminished smooth muscle cell marker expression.
Transverse sections of embryos at E10.5 (A) and E11.5 (B) were stained
for SMA (red) and Pecam1 (green). Notch2
2/2 (N2
2/2;N3
+/+) and
Notch2
2/2;Notch3
2/2 (N2
2/2;N3
2/2) embryos exhibit less SMA-positive
cells in the dorsal aorta at E10.5 compared to wild-type and Notch3
2/2
(N2
+/+;N3
2/2) embryos, while Pecam1 levels are similar in all genotypes.
At E11.5, Notch2
2/2;Notch3
2/2 embryos show an even greater loss of
SMA expression, with increased vessel diameter. Merged images also
show DAPI stain (blue) to highlight nuclei. Scale bar=100 mm.
doi:10.1371/journal.pone.0037365.g004
Figure 5. SMA expression is decreased in yolk sacs of Notch2
and Notch2/Notch3 double mutant embryos. Yolk sacs collected
at E11.5 were stained for SMA (red) and Pecam1 (green). SMA is
prominently expressed around the blood vessels in yolk sacs of
wildtype and Notch3
2/2 (N2
+/+;N3
2/2) embryos, whereas its expression
is significantly decreased in Notch2
2/2 (N2
2/2;N3
+/+) and Notch2
2/2;
Notch3
2/2 (N2
2/2;N3
2/2) vessels. Yolk sacs of the Notch2
2/2;Notch3
2/2
embryos have blood vessels that appear structurally deficient
compared to the other genotypes. Scale bar=100 mm.
doi:10.1371/journal.pone.0037365.g005
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SMA and SM22a, implying that these Notch receptors are not
completely necessary for the expression of these smooth muscle
marker genes during differentiation. Additional signaling pathways
are likely involved in maintaining expression during differentia-
tion, such as those driven by TGFß or serum response factor (SRF)
[23].
Previously it was shown that endothelial cell-expressed Notch
ligand Jagged1 is critical for smooth muscle differentiation [9].
Our previous data and findings shown here, indicate that Notch3
expression, but not Notch2 is induced by Notch signaling [14].
Possibly, within smooth muscle cells Notch2 is activated by the
Jagged1 ligand on neighboring endothelial cells to establish the
first wave of Notch activation and differentiation. During this
phase, Notch2 activates not only smooth muscle genes, but also
Notch3 expression and together they drive the differentiation
program. In the absence of Notch2, smooth muscle differentiation
is delayed slightly, however the presence of Notch3 can maintain
vascular integrity. In the absence of Notch3, Notch2 expression is
sufficient for the initiation of smooth muscle differentiation, but is
not capable of the fine-tuning required for the later steps of
maturation. In the absence of both genes, smooth muscle cells
cannot differentiate properly, the vessels carrying blood through
the embryos fail, resulting in hemorrhaging and eventual collapse
of the vessel. Overall, our data show for the first time a critical role
for Notch receptors in vascular smooth muscle development, and
suggest that propagation of Notch signaling in this cell type
requires the combined efforts of Notch2 and Notch3. The actual
mechanisms by which Notch2 and Notch3 coordinate to regulate
vascular development are not known. Differences in how they are
Figure 6. Smooth muscle differentiation and Notch target genes are down regulated in Notch2 and Notch2/Notch3 double
mutants. Gene expression analysis (qPCR) using yolk sac RNA demonstrates a reduction of smooth muscle-specific genes SMA, SM22a, and Cnn1 in
Notch2
2/2 (N2
2/2;N3
+/+) and Notch2
2/2;Notch3
2/2 (N2
2/2;N3
2/2). Notch signaling target gene Heyl shows a robust decrease at E10.5 and E11.5 in
the Notch2
2/2 (N2
2/2;N3
+/+) and Notch2
2/2;Notch3
2/2 (N2
2/2;N3
2/2) yolk sacs, while Hey2 shows a slight decrease and Hes1 expression is
unaffected in the mutant genotypes. Data represent relative mRNA expression levels normalized to 18S rRNA. * P,0.05, ** P,0.01 compared to
wildtype.
doi:10.1371/journal.pone.0037365.g006
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individual temporal functions that converge within blood vessels.
Alternatively, unique structural features of each Notch family
member could contribute to distinct downstream interactions and
responses that when acting together shape the vascular landscape.
Materials and Methods
Ethics statement
All mouse studies were carried out in accordance with protocols
approved by the Institutional Animal Care and Use Committee
(IACUC) at the Research Institute at Nationwide Children’s
Hospital. The Nationwide Children’s Hospital Research Institute
IACUC specifically approved this study.
Mouse lines, genotyping and crosses
All strains were maintained in C57Bl/6 background. Notch2
del1
[17] and Notch3
dl [19] single mutant mice were generated and
generously provided by Dr. Thomas Gridley. Notch2
del1/+, referred
to here as Notch2
2/+ (N2
2/+) mice were crossed with Notch3
dl/dl,
referred to here as Notch3
2/2 (N3
2/2) mice to generate Notch2
2/+;
Notch3
2/+ double heterozygous mice. To produce embryos for
analysis, Notch2
2/+;Notch3
2/+ mice were intercrossed. Nine differ-
ent genotypes of embryos were generated and collected as shown
Figure 7. NICD2 and NICD3 can directly activate Notch targets and smooth muscle marker genes. Activated forms of Notch2 (NICD2)
and Notch3 (NICD3) were introduced into human aortic smooth muscle cells by lentiviral transduction, followed by qPCR to analyze gene expression.
Both NICD2 and NICD3 robustly activate expression of smooth muscle genes, SMA, CNN1, and SM-MHC (A), and also activate Notch targets HEYL,
HEY2, and HES1 (B), compared to a GFP-expressing control. Both NICD2 and NICD3 activate endogenous NOTCH3 expression, but not NOTCH2
expression (C). Western blot demonstrates expression of the NICD2 and NICD3 constructs with a FLAG antibody (D). Data represent relative mRNA
expression levels normalized to 18S rRNA. * P,0.05, ** P,0.01 compared to GFP control.
doi:10.1371/journal.pone.0037365.g007
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expected Mendelian segregation. Embryos were considered
embryonic (E) day 0.5 (E0.5) at the day when vaginal plug was
observed. Genotyping of mice and embryos was carried out by
PCR with Notch2wtsp3: 59-CCA GTG TGC CAC AGG TAA
GTG-39, Notch2wtsp4: 59-TCT CCA TAT TGA TGA GCC
ATG C-39, Notch2dlsp6: 59 –TTC CTG ACT AGG GGA GGA
GTA G-39. Notch3wt1: 59-CCA TGA GGA TGC TAT CTG
TGA C-39, Notch3wt2: 59-CAC ATT GGC ACA AGA ATG
AGC C-39, Notch3dl1: 59-GGT ACT GAG AAC CAA ACT
CAG C-39, Notch3dl2: 59-TCG CCT TCT ATC GCC TTC
TTG A-39.
Quantitative RT-PCR (qPCR)
Total RNA was extracted using RNeasy Mini Kit (QIAGEN,
Cat: 74104) from a minimum of five yolk sacs corresponding to
each genotype. RNA from cultured cells was isolated by TRIzol
(Invitrogen). Reverse transcription was performed using M-MLV
reverse transcriptase (Invitrogen, Cat: 28025-013). SYBR green
detection of PCR amplicons was performed using an ABI qPCR
machine. Corresponding gene expression level was normalized to
18S rRNA or Gapdh from the same sample. Primer sequences are
listed in Table S2.
Whole-mount immunohistochemistry
Embryos or yolk sacs were harvested in cold phosphate buffered
saline (PBS) and fixed in 4% paraformaldehyde overnight at 4uC
or 1 hour at room temperature. For embryo staining, the embryos
were dehydrated in a graded methanol series, and bleached with
Methanol: DMSO: 3% H2O2 (4:1:1) or PBS: 3% H2O2 (4:1) to
block endogenous peroxidase. Embryos were then blocked and
permeabilized with 5% instant nonfat milk or goat serum and
0.3% Triton-X-100. Primary antibodies, Smooth muscle a-actin
(SMA) (1:500, SIGMA, Cat: A2547) or Pecam1 (1:50, BD
Pharmingen, Cat: 550274) were incubated overnight at 4uC,
followed by incubation with appropriate HRP-conjugated second-
ary antibody (1:500) overnight at 4uC. The color reaction was
done in PBT (PBS+0.1% tween-20) containing 0.5 mg/ml 3,39-
diaminobenzidine (DAB, SIGMA, Cat: D-5673) and 0.01%
H2O2. Embryos were dehydrated and cleared in benzyl alcohol:
benzyl benzoate (1:2) (SIGMA). Pictures were captured with a
dissecting microscope (Leica, M156C). Immunostaining of whole
yolk sacs was performed as previously described with modifications
[13]. In brief, after fixation, yolk sacs were placed in cold methanol
for 10 minutes, blocked in 5% goat serum and 0.3% Triton-X-100
for 1 hour at room temperature, followed by Pecam1 and SMA
antibody incubation for 2 hours at 37uC. Yolk sacs were then
incubated with AlexaFluor-conjugated second antibody overnight
at 4uC. After washing in PBT, yolk sacs were flattened and
mounted in aqueous mounting medium (LERNER LABORA-
TORIES, Cat: 13800). Images were captured using a confocal
microscope (Zeiss LSM 710).
Histological analysis of embryos
After fixation, embryos were processed, embedded in paraffin,
and sectioned at 8 mm. Hematoxylin and eosin staining was
performed by standard staining protocol. For immunohistochem-
istry, sections were baked at 60uC for 1 hour, cleared in xylene,
rehydrated through a descending concentration of ethanol for
2 minutes each ending in distilled water. Antigen retrieval was
done in citrate buffer (0.01 M, PH=6.0) using a pressure cooker
for 30 minutes. Sections were cooled to room temperature and
blocked with 5% goat serum diluted in PBS with 0.5% Triton-X-
100 for 1 hour at room temperature. Sections were then incubated
with primary antibody, SMA (1:1000, SIGMA, Cat: A2547), and
Pecam1 (1:250, Santa Cruz, sc-1506-R) overnight at 4uC. After
washing in PBT, sections were incubated with appropriate
AlexaFluor–conjugated secondary antibody (1:500 Invitrogen)
for 1 hour at room temperature, counterstained with DAPI, and
mounted in Vectashield mounting medium (Vector Laboratories,
H-1400). Pictures were taken using a fluorescence microscope
(OLYMPUS, 1X51).
Cell culture and lentiviral expression of NICD2 and NICD3
Human aortic smooth muscle cells (HAoSMC) were purchased
from Lonza and cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM) (Mediatech, Inc.) supplemented with 10% fetal bovine
serum (FBS) (Hyclone), 2 mM glutamine, 1 mM sodium pyruvate
and 100 U/ml penicillin-streptomycin. Cells between passages 6–
9 were used for all experiments. For virus production, TN293 cells
were purchased from Stratagene and cultured in 10% DMEM as
above. All cultures were maintained in humidified 5% CO2 at
37uC. Human NOTCH2 intracellular domain (NICD2) cDNA (a
gift from Dr. Igor Prudovsky) was cloned with a 36-FLAG-tag
attached to the 59 end into pCDF1-MCS2-EF1-copGFP (System
Biosciences). NOTCH3 intracellular domain (NICD3) with a 36-
FLAG-tag was made as described previously [14]. The lentivirus
plasmids were transfected into TN-293 cells using Lipofectamine
2000 (Invitrogen), and the viral particles were amplified and
purified as described [14]. Equal volumes of viral particles were
diluted in 10% FBS in DMEM and were incubated with cells for
24 hours. The efficiency of infection was evaluated using GFP
expression and qPCR. Viral particles were titrated to achieve 90%
to 100% infection. Expression of cDNAs were confirmed using
qPCR (not shown) and Western blot analysis using a FLAG
antibody (SIGMA, F1804) (Figure 7).
Statistical analysis
Data shown are representatives of at least three independent
experiments and are presented as mean 6 standard error of the
mean (SEM). Data analyses were conducted using GraphPad
Prism and comparisons of the data among 4 different groups were
made using One-way ANOVA, followed by Newman-Keuls test.
Differences were considered significant if P,0.05.
Supporting Information
Figure S1 Hematoxylin and eosin staining of transverse
sections of E10.5 embryos through the descending aorta.
The overall structure of blood vessels appears relatively normal in
the single mutant Notch2
2/2 (N2
2/2;N3
+/+), Notch3
2/2 (N2
+/+;
N3
2/2) and double mutant, Notch2
2/2;Notch3
2/2 (N2
2/2;N3
2/2)
embryos. 406magnification.
(PDF)
Figure S2 Quantification of Pecam1 and SMA staining
of sectioned aortas. Staining of Pecam1and SMA was quantified
by measuring the number of pixels with a set intensity and
normalizing to vessel circumference. (A) At E10.5, the Notch2
2/2
(N2
2/2;N3
+/+) and Notch2
2/2;Notch3
2/2 (N2
2/2;N3
2/2) embryos
exhibit less SMA-positive staining intensity. (B) At E11.5, both
Pecam1 and SMA expression is significantly reduced in the Notch2
and double mutant aortas. Notch2
2/2;Notch3
2/2 embryos show an
even greater loss of SMA expression compared to the Notch2
2/2
mice. P,0.05, * compared to wildtype control, # compared to
Notch2
2/2.
(PDF)
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have structurally normal hearts. Transverse sections from
wildtype and mutant embryos at E10.5 were stained for SMA (red)
and Pecam1 (green) (A). All mutant embryos have normal SMA
expression in the cardiomyocytes and Pecam1 staining of the
endocardial cells. H&E staining of transverse sections through the
outflow tract of wildtype and mutant embryos at E10.5 and E11.5
(B). At E10.5, hearts of the double mutant embryos are comparable
to wildtype and single mutant embryos. A day later the Notch2/
Notch3 double mutant embryo’s outflow tract show signs of cellular
atrophy, whereas the other three genotypes appear structurally
normal. Notch2
2/2 (N2
2/2;N3
+/+), Notch3
2/2 (N2
+/+;N3
2/2)a n d
double mutant, Notch2
2/2;Notch3
2/2 (N2
2/2;N3
2/2) embryos.
106magnification.
(PDF)
Table S1 Recovery of Notch2 (N2) and Notch3 (N3)
mutant embryos at various gestational ages.
(PDF)
Table S2 Quantitative RT-PCR primer sequences.
(PDF)
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